Statistics for Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial
Total visits
| views | |
|---|---|
| Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial | 114 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| 13063_2021_Article_5235.pdf | 89 |
Top country views
| views | |
|---|---|
| United States | 47 |
| Canada | 23 |
| Ireland | 15 |
| United Kingdom | 8 |
| Germany | 5 |
| Finland | 4 |
| China | 3 |
| Cyprus | 2 |
| France | 2 |
| Vietnam | 2 |
| Belgium | 1 |
| Japan | 1 |
| Netherlands | 1 |
Top city views
| views | |
|---|---|
| Winnipeg | 20 |
| Dublin | 15 |
| Inglewood | 14 |
| Wolverhampton | 7 |
| Philadelphia | 6 |
| The Dalles | 6 |
| Ashburn | 5 |
| Helsinki | 4 |
| Brooklyn | 3 |
| Zhengzhou | 3 |
| Hanoi | 2 |
| Brussels | 1 |
| Camden | 1 |
| Dallas | 1 |
| Des Moines | 1 |
| Dronten | 1 |
| Nagold | 1 |
| Seattle | 1 |
| Tokyo | 1 |
| Toronto | 1 |